Acetylsalicylic acid in low dose for primary prevention of cardiovascular disease Do not misinterpret the recommendations

被引：0
|
作者：
Truong, Christine [1 ]
机构：
[1] Equipe Sante Familiale North York, Toronto, ON, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2015年 / 61卷 / 11期
关键词：
ASPIRIN; THERAPY; RISK;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：973 / 975
页数：3
相关论文
共 50 条
  • [1] Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease
    Lamotte, Mark
    Pinol, Carme
    Brotons, Carlos
    Annemans, Lieven
    Guardiola, Elena
    Evers, Thomas
    Kubin, Maria
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (08): : 807 - 815
  • [2] Low-dose acetylsalicylic acid and upper gastrointestinal bleeding in primary and secondary cardiovascular disease prevention populations
    Lin, K. J.
    De Caterina, R.
    Garcia Rodriguez, L. A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 437 - 437
  • [3] Do type 2 diabetes patients require acetylsalicylic acid for primary prevention of cardiovascular disease?
    Pavlicek, V.
    DIABETOLOGE, 2008, 4 (08): : 655 - 656
  • [4] Acetylsalicylic acid on primary prevention of cardiovascular diseases
    Nicolini, Francesco
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (07) : 743 - 745
  • [5] Acetylsalicylic acid for primary prevention of cardiovascular events
    Fritsch, Paul
    Kolber, Michael R.
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (07) : 480 - 480
  • [6] Use of low-dose acetylsalicylic acid for cardiovascular disease prevention: A practical, stepwise approach for pharmacists
    Barry, Arden R.
    Semchuk, William M.
    Thompson, Ann
    LeBras, Marlys H.
    Koshman, Sheri L.
    CANADIAN PHARMACISTS JOURNAL, 2020, 153 (03) : 153 - 160
  • [7] Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes
    Garcia Rodriguez, Luis A.
    Cea Soriano, Lucia
    Martin-Merino, Elisa
    Johansson, Saga
    CIRCULATION, 2009, 120 (18) : S480 - S480
  • [8] Acetylsalicylic acid and prevention of fatal outcomes in cardiovascular disease: selecting medication form and dose
    Averkov, O. V.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (04): : 82 - 86
  • [9] Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
    Li, Xiao-Ying
    Li, Li
    Na, Sang-Hoon
    Santilli, Francesca
    Shi, Zhongwei
    Blaha, Michael
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 11
  • [10] Update on acetylsalicylic acid for primary prevention of cardiovascular disease Not initiating is not the same thing as discontinuing
    Truong, Christine
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (07) : 481 - 482
12345